| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |